Gor, who was speaking at an event at the Indian Institute of Technology (IIT)-Delhi, described the relationship with New Delhi as the “defining partnership” of the 21st century, driven increasingly by technology, strategic trust and economic cooperation.
The Ambassador’s comments come as India and the US continue negotiations on an interim trade deal, with a US team set to visit next month to firm up the details.
Gor said no partnership was better positioned than the relationship between “our trusted partner” India and the US to seize emerging opportunities, particularly in critical and emerging technologies. “The US trusts India, which is our partner. And we trust your government. There is limitless potential to take forward the US-India relationship,” he said, adding that there was opportunity to transform bilateral ties into a more seamless economic partnership.
Highlighting the recently launched US-India TRUST (Transforming the Relationship Utilising Strategic Technology) initiative, Gor said the framework reflected the depth of trust between the two countries.
The TRUST initiative was announced during Prime Minister Narendra Modi’s visit to Washington last year. It aims to strengthen critical supply chains while boosting collaboration between governments, academia and the private sector in advanced technologies.
Gor also welcomed India’s efforts to frame rules and regulations for greater private sector participation in the civil nuclear sector.He described US Secretary of State Marco Rubio’s recent India visit as “substantive”, signalling continued high-level engagement between the two countries across trade, technology and strategic domains.
Gor indicated that the US was recalibrating its export control policies in a manner that could help deepen cooperation with India in sensitive high-technology sectors.
The growing trust between the two countries, he said, was visible in sectors ranging from artificial intelligence and semiconductors to pharmaceuticals and space cooperation.
The envoy said AI data centres were expected to be built in India with American participation, while investments are flowing both ways between Indian and US companies.
“Investors come to us and ask whether it is safe to invest in India. Our answer is yes,” he said.
Gor pointed out that the US imports nearly 40% of its pharma supplies from India, which he said reflects confidence in Indian manufacturing capabilities.
“This is because we trust India,” he said, while noting that Indian companies have announced investments worth $20.5 billion in the US, with a significant share coming from the pharmaceutical sector.